Screener
Mirum Pharmaceuticals, Inc. MIRM Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The source filing: Mirum Pharmaceuticals, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001759425-26-000045
FAQ
- What is Mirum Pharmaceuticals, Inc.'s retained earnings?
- Mirum Pharmaceuticals, Inc. (MIRM) reported retained earnings of -$1.52B in Q2 2026.
- How has Mirum Pharmaceuticals, Inc.'s retained earnings changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s retained earnings decreased by 129.4% year-over-year, from -$664.72M to -$1.52B.
- What is the long-term trend for Mirum Pharmaceuticals, Inc.'s retained earnings?
- Over 5 years (2020 to 2025), Mirum Pharmaceuticals, Inc.'s retained earnings has grown at a 31.0% compound annual growth rate (CAGR), from -$173.17M to -$667.54M.
- What does retained earnings mean?
- Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.
Ask your AI about Mirum Pharmaceuticals, Inc.'s retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude